Unicycive Therapeutics, Inc., (UNCY) Social Stream
UNICYCIVE THERAPEUTICS INC (UNCY) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering UNCY.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-03-31 | 2 | $13.5 | $13 | $13.25 | $0.895 | 1380.45% |
| 2022-05-12 | 3 | $13.5 | $3 | $9.833 | $0.895 | 998.66% |
| 2022-08-16 | 4 | $13.5 | $3 | $9.625 | $0.895 | 975.42% |
| 2022-11-14 | 3 | $13.5 | $3 | $9.625 | $0.895 | 975.42% |
| 2022-11-28 | 3 | $13.5 | $3 | $9.375 | $0.895 | 947.49% |
| 2023-03-17 | 3 | $13 | $5 | $8 | $0.895 | 793.85% |
| 2023-04-03 | 3 | $24 | $6 | $12.75 | $0.895 | 1324.58% |
| 2023-04-06 | 4 | $24 | $5 | $11.2 | $0.895 | 1151.4% |
| 2023-05-17 | 4 | $24 | $5 | $10.75 | $0.895 | 1101.12% |
| 2023-06-20 | 5 | $24 | $3 | $9.2 | $0.895 | 927.93% |
| 2023-06-30 | 5 | $24 | $3 | $8.8 | $0.895 | 883.24% |
| 2023-07-07 | 4 | $7 | $3 | $4.75 | $0.895 | 430.73% |
| 2023-11-16 | 4 | $5.001 | $3 | $4.125 | $0.895 | 360.89% |
The Trend in the Analyst Price Target
Over the past 27 months, UNCY's average price target has gone down $9.42.
UNCY reports an average of 484.43% for its upside potential over the past 36 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-17 | 3 | 13.000 | 5 | 8.000 | 2.090 | 282.78% |
| 2023-04-06 | 4 | 24.000 | 5 | 10.750 | 2.070 | 419.32% |
| 2023-06-30 | 5 | 24.000 | 3 | 8.800 | 1.280 | 587.5% |
| 2023-07-03 | 5 | 7.000 | 3 | 4.600 | 1.150 | 300% |
| 2023-11-16 | 4 | 5.001 | 3 | 4.125 | 0.513 | 704.09% |
UNCY Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 3 | 0 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
Over the past 14 months, UNCY's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how UNICYCIVE THERAPEUTICS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 2016.64% of that group.
- To contextualize these metrics, consider that out of all US stocks, UNICYCIVE THERAPEUTICS INC's average analyst price target is greater than 196.64% of them.
- In terms of how UNICYCIVE THERAPEUTICS INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 238.79% of that group.
- In the context of all US stocks, UNICYCIVE THERAPEUTICS INC's variance in analysts' estimates is lower than -1557.25% of them.
Stocks similar to UNICYCIVE THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are DRMA, LIPO, and CVKD.
View All Top Stocks by Price Target
Make investment decisions regarding UNCY using the data that counts. Try POWR Ratings for free.